Pharmacopeia
CWP-0002
ABCIXIMAB
Haematology · Haematology · Level 3
Core pharmacology
- Class Group
Antiplatelet
- Legacy Cicm Level
Level 3
- Introduction
GP IIb/IIIA Inhibitor
- Main Action
Platelet inhibition
- Mechanism of action
Similar mechanism as tirofiban but monoclonal
antibody- Adverse Effects Toxicity
Haemorrhage, thrombocytopenia, human antichimeric antibody development, allergic reaction
- Metabolism
Platelet function
typically returns to
normal 24-48 hours after
infusion ceases- Excretion
Platelet function
typically returns to
normal 24-48 hours after
infusion ceases